Dr. Michele Tagliati, an associate professor of neurology and director of the Parkinson's Disease Center at the Mount Sinai School of Medicine in New York City, described the study as "eye-opening" and stressed the need for further study in the area.
added that he
would now "definitely discuss ibuprofen use" with his
This is due to the fact that if helps protect against the disease, it may also benefit those who already have Parkinson's disease.
Doctors have cautioned that continual use of ibuprofen can lead to gastritis (inflammation of the stomach lining).
responds that, in comparison, the effects of gastritis are significantly less than the effects of Parkinson's which can include loss of balance, stiffness, hallucinations and dementia.